The Clinical Trials Unit focuses on investigation of drug therapies with the potential to modify diseases previously considered untreatable, such as Fragile X syndrome, tuberous sclerosis complex (TSC), and autism.
The Clinical Trials Unit at Kennedy Krieger Institute is a resource that researchers and clinicians can use to apply and participate in future industry- and privately- sponsored clinical trials. It serves as a center of excellence within the Institute for the development, coordination, and implementation of clinical trials designed to advance the scientific knowledge of a wide range of neurological disorders.
We are currently accepting participants for active trials. Please contact us at ResearchTrials@KennedyKrieger.org if you have any questions or are interested in more information about a specific trial.